March 25, 2021
Here is the link.
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of various therapies for the treatment of cancer and related conditions in North America and Asia. Analyst average twelve-month price target is $15.00, predicting that the stock has a possible upside of 192.11%. The high price target for ATNX is $33.00 and the low price target for ATNX is $5.00. There are currently 6 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Hold." DISCLAIMER: I am not a financial advisor, nor do I claim to be. Videos are for entertainment and educational purposes only. Investing of any kind involves risk. Everything you watch on my channel is my opinion. These are not suggestions or directions as to how to handle your money. It is important that you conduct your own research.
No comments:
Post a Comment